Skip to main content
. 2013 Oct 20;6:95–111. doi: 10.4137/MRI.S12561

Table 4.

Gadolinium-based contrast media classified according to CHMP categorization of NSF risk (CHMP 2009).80

  • High risk: gadoversetamide, gadodiamide, gadopentetate dimeglumine

  • Medium risk: gadofosveset trisodium, gadoxetate disodium, gadobenate dimeglumine

  • Low risk: gadoterate meglumine, gadoteridol, gadobutrol

Abbreviations: CHMP, Committee for Medicinal Products for Human Use; NSF, nephrogenic systemic fibrosis.